Reduction of hepatitis C virus using lectin affinity plasmapheresis in dialysis patients

Blood Purification

Volumn 27, Issue 1, 2009, Pages 64-69

  Tullis, Richard H ^a   Duffin, R Paul ^a   Handley, Harold H ^a   Sodhi, Puneet ^b   Menon, Jeevan ^a   Joyce, James A ^a   Kher, Vijay ^b  

^a Aethlon Medical Inc   (United States)

^b FORTIS HOSPITAL   (India)

Author keywords

Galanthus nivalis agglutinin; Hemodialysis; Hepatitis C virus; Lectin affinity

Indexed keywords

AGGLUTININ; LECTIN; VIRUS RNA;

BLOOD SAMPLING; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DIALYSIS; HEMODIALYSIS PATIENT; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KIDNEY FAILURE; PLASMA CLEARANCE; PLASMAPHERESIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERODIAGNOSIS; TREATMENT DURATION; VIRUS LOAD;

CHROMATOGRAPHY, AFFINITY; HEPACIVIRUS; HEPATITIS C; HUMANS; KIDNEY FAILURE, CHRONIC; LECTINS; PLASMAPHERESIS; POLYMERASE CHAIN REACTION; RNA, VIRAL; VIRAL LOAD;

EID: 58849109357     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000167011     Document Type: Conference Paper

References (15)

1. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, Margolis HS: The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556-562.
2. Worman HT: The Hepatitis C Sourcebook, ed 1. New York, McGraw-Hill, 2002.
3. Bendinelli M, Pistello M, Maggi F, Vatteroni M: Blood-borne hepatitis viruses: hepatitis B, C, D and G viruses and TT virus; in Specter SC, Hodinka RL, Young SA (eds): Clinical Virology Manual, ed 3. Washington, ASM Press, 2000.
4. Robertson B, Myers G, Howard C, Brettin T, Bukh J, Gaschen B, Gojobori T, Maertens G, Mizokami M, Nainan O, Netesov S, Nishioka K, Shin i T, Simmonds P, Smith D, Stuyver L, Weiner A: Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy. Arch Virol 1998;143:2493-2503.
5. Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, Halfon P, Inchauspe G, Kuiken C, Maertens G, Mizokami M, Murphy DG, Okamoto H, Pawlotsky JM, Penin F, Sablon E, Shin-I T, Stuyver LJ, Thiel HJ, Viazov S, Weiner AJ, Widell A: Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 2005;42:962-973.
6. da Silva Cardoso M, Siemoneit K, Sturm D, Krone C, Moradpour D, Kubanek B: Isolation and characterization of human monoclonal antibodies against hepatitis C virus envelope glycoproteins. J Med Virol 1998;55:28-34.
7. Ralston R, Thudium K, Berger K, Kuo C, Gervase B, Hall J, Selby M, Kuo G, Houghton M, Choo QL: Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses. J Virol 1993;67:6753-6761.
8. Owsianka A, Clayton RF, Loomis-Price LD, McKeating JA, Patel AH: Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2. J Gen Virol 2001;82:1877-1883.
9. Badalamenti S, Catania A, Lunghi G, Covini G, Bredi E, Brancaccio D, Salvadori M, Como G, Ponticelli C, Graziani G: Changes in viremia and circulating interferon-alpha during hemodialysis in hepatitis C virus-positive patients: only coincidental phenomena? Am J Kidney Dis 2003;42:143-150.
10. Fernandez JL, Valtuille R, Butera H, Fay F, Lef L, Rendo P: Influence of hemodialysis procedure on HCV RNA detection in serum and peripheral blood mononuclear cells. Ren Fail 2004;26:369-373.
11. Mizuno M, Higuchi T, Yanai M, Kanmatsuse K, Esumi M: Dialysis-membrane- dependent reduction and adsorption of circulating hepatitis C virus during hemodialysis. Nephron 2002;91:235-242.
12. Fabrizi F, Bunnapradist S, Lunghi G, Martin P: Kinetics of hepatitis C virus load during hemodialysis: novel perspectives. J Nephrol 2003;16:467-475.
13. Ramratnam B, Bonhoeffer S, Binley J, Hurley A, Zhang L, Mittler JE, Markowitz M, Moore JP, Perelson AS, Ho DD: Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis. Lancet 1999;354:1782-1785.
14. Tullis RH, Duffin RP, Zech M, Ambrus JL Jr: Affinity hemodialysis for antiviral therapy. 1. Removal of HIV-1 from cell culture supernatants, plasma, and blood. Ther Apher 2002;6:213-220.
15. Andre P, Komurian-Pradel F, Deforges S, Perret M, Berland JL, Sodoyer M, Pol S, Brechot C, Paranhos-Baccala G, Lotteau V: Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J Virol 2002;76:6919-6928.